Study to Evaluate the Safety and Effectiveness of IRay in Wet Age-related Macular Degeneration (AMD) Patients With Recurrent Leakage Secondary to Choroidal Neovascularisation (CNV)

Stopped Sponsor decision to withdraw study to pursue others.

Conditions

• Wet Age-related Macular Degeneration
• Age-related Macular Degeneration
• AMD
• Wet AMD
• Macular Degeneration

Interventions

• DEVICE: IRay
• DEVICE: IRay

Sponsor

Oraya Therapeutics, Inc.